Navigation Links
Rilpivirine for HIV: Added benefit for single agent proven
Date:12/7/2012

Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant) and by the other as a fixed combination with other HIV drugs (trade name Eviplera). In two early benefit assessments pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the Institute for Quality and Efficiency in Health Care (IQWiG) has investigated whether the two new drugs have advantages over current standard therapies.

According to IQWiG, there is proof that rilpivirine as a single agent offers a considerable added benefit to men infected with HIV-1. For women, the available studies provide corresponding "indications" of considerable added benefit.

On the other hand, no added benefit can be derived from the manufacturer's dossier for the fixed combination - although precisely the same studies were available to the two pharmaceutical companies. This is because, unlike the manufacturer of the single agent, the company making the fixed combination product did not analyse the study data in a suitable way. Hence the contents of its dossier are incomplete.

G-BA specifies efavirenz as the appropriate comparator therapy

Two pharmaceutical companies introduced the new drug onto the market in Germany at the same time; one as a single agent and one in a fixed combination with emtricitabine and tenofovir. Both products are approved for adults who are beginning a treatment directed at stopping the multiplication of the virus for the first time and in whom not more than 100,000 viral components can be detected per millilitre of blood.

The Federal Joint Committee (G-BA) has in each case specified efavirenz-based therapy in combination with other drugs as the appropriate comparator therapy.

Studies on the single agent als
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
0049-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. No Added Cancer Risk From Hip Replacement Materials: Study
2. Tafamidis: Approval denotes proven added benefit
3. Nurse Alert Provides Added Level of Senior Alert Care With New Nurse Triage Feature
4. Abiraterone: Indication of considerable added benefit in certain patients
5. Collagenase for Dupuytrens contracture: Added benefit not proven
6. Added benefit of linagliptin is not proven
7. Added benefit of eribulin in breast cancer is not proven
8. Added benefit of fampridine is not proven
9. Belimumab for lupus erythematosus: Added benefit not proven
10. Keeping Up a Healthy Lifestyle Pays Off in Added Years: Study
11. Telaprevir: Added benefit in certain patients with hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, has released ... products are available at low rates up to 30% ... the new emergency doors. The emergency door adopts fireproof ... from several colors. All of the products are top-quality ... is not as easy as many people think. ...
(Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... the past month in a federal litigation involving Byetta ... similar diabetes medications, Bernstein Liebhard LLP reports. , ... 566 claims over a class of Type 2 diabetes ... filed in the U.S. District Court, Southern District of ...
(Date:11/23/2014)... Church, VA (PRWEB) November 23, 2014 ... TV Have in Common, **FDAnews On-Demand Webinar**, Dec. 11, ... http://www.fdanews.com/TheFDAisWatchingOnDemand , The FDA’s focus on promotional activities ... , Now they're looking at websites, Twitter, ... Mark the calendar for Thursday, Dec. 11, for On-Demand ...
(Date:11/23/2014)... 2014 Today Zane Benefits, the ... businesses, announced their new on demand webinar which ... Health Insurance. , According to Zane ... risk facing most American families. It is also ... large, when it comes to recruiting and retaining ...
(Date:11/22/2014)... 2014 PrettyTailor , an outstanding ... new big promotion. Customers can buy new dresses at ... can visit its website. , As a matter of ... dresses. It mainly provides four types of wedding outfits, ... flower girl dresses. It also provides a variety of ...
Breaking Medicine News(10 mins):Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2
... TUESDAY, June 7 (HealthDay News) -- Male and female military ... mental health problems and recover at the same rate, a ... examine the role of gender on combat-linked stress after deployment ... and women deployed between October 2007 and July 2008 in ...
... HealthDay Reporter , TUESDAY, June 7 (HealthDay News) ... Europe makes headlines, U.S. health officials announced Tuesday that salmonella, ... Americans. In fact, while rates of several types of ... falling over the past 15 years, there,s been no progress ...
... A new drug to treat prostate cancer shows early promise, ... multi-site study shows. The drug Cabozantinib is designed to ... spread of prostate cancer. The drug had the most effect ... only did three-quarters of bone scans have partial or complete ...
... (HealthDay News) -- Mental health problems are the leading ... worldwide, according to a new study. Researchers who ... disorders -- including depression, schizophrenia, bipolar disorder and alcohol ... burden among those 10 to 24 years old. ...
... a dazzling array of people, objects, sounds, smells and events: ... moment. So our attention may automatically be snagged by something ... focus on something that is important to us right then, ... on the school playground. We also know that people are ...
... , TUESDAY, June 7 (HealthDay News) -- Abnormalities ... signal conditions involving both the heart and lungs, according to ... study of the heart,s right ventricle, or lower right chamber, ... right side of a person,s heart differs, depending on their ...
Cached Medicine News:Health News:Women Exposed to Combat Trauma as Resilient as Men: Study 2Health News:Women Exposed to Combat Trauma as Resilient as Men: Study 3Health News:Women Exposed to Combat Trauma as Resilient as Men: Study 4Health News:In U.S., Salmonella Is on the Rise While E. Coli Retreats 2Health News:In U.S., Salmonella Is on the Rise While E. Coli Retreats 3Health News:In U.S., Salmonella Is on the Rise While E. Coli Retreats 4Health News:Drug shows promise in prostate cancer spread to bone 2Health News:Study Ranks Mental Health as Young People's Top Health Problem 2Health News:Your attention please: 'Rewarding' objects can't be ignored 2Health News:Your attention please: 'Rewarding' objects can't be ignored 3Health News:Right Side of Heart Linked to Lung Diseases, Study Finds 2
(Date:11/21/2014)... 21. November 2014 ... bekannt gegeben, dass die Europäische Arzneimittel-Agentur ... Kennzeichnung als Orphan-Medizinprodukt an Palovarotene vergeben ... zur Behandlung von Fibrodysplasia ossificans progressiva ... beeinträchtigende genetische Krankheit, die von schmerzhaften, ...
(Date:11/21/2014)... and MELVILLE, N.Y. , Nov. 21, ... ), one of the world,s largest health care services ... ), the world,s largest provider of health care products ... practitioners, today announced that the companies have entered into ... most comprehensive service and product offerings to office-based medical ...
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... Not for release, publication or distribution, in whole or in ... where to do so would constitute a violation of the relevant laws ... BY ALERE AS HOLDINGS LIMITED ("ALERE AS HOLDINGS" OR ... FOR AXIS-SHIELD PLC ("AXIS-SHIELD" OR THE ...
... MIAMI and ATLANTA, Sept. 26, 2011 ASTRO Booth ... Oncology (ASTRO) 53rd Annual Meeting, October 2-6 in Miami ... solutions designed to simplify the complex processes involved in ... Elekta technology. "Radiotherapy techniques are becoming ...
Cached Medicine Technology:Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 2Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 3Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 4Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 5Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 6Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 7Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 8Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 9Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 10Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 11Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 12Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 13Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 14Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 2Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 3
... trauma procedures. Part of the osi ... table top provides a complete, powered, ... and provides for skin or skeletal ... pinnings; femur, supine or lateral im ...
... (PEMF) bone growth stimulation delivered by Physio-Stim ... bone and small bone nonunions. Physio-Stim may ... or clothing without lessening its effectiveness. Physio-Stim ... lightweight unit including success rates as high ...
Guardsman Femoral Interference Screw is specifically designed for endoscopic femoral fixation where graft protection is needed....
BioScrew® Bio-Absorbable Interference Screws and Delivery System Clinically equivalent to metal interference screws....
Medicine Products: